(+64) 09 302 0221
70 Symonds Street, Grafton, Auckland, Auckland 1010
Info@apercure.comg.watts@apercure.com
Apercure Surgical was founded by a surgeon and a scientist with over 50 years of combined experience, bringing firsthand clinical insights into solving everyday challenges in healthcare. Emerging from a pioneering medical device design studio at the University of Auckland, New Zealand, our mission is to create practical, impactful solutions that improve patient outcomes while delivering economic value to healthcare providers. By leveraging rapid design, prototyping, and testing, we specialise in developing innovative medical device solutions.
Our current focus is on enhancing the security and comfort of drain retention devices for medical and radiological interventions. These advancements aim to transform the experiences of both patients and clinicians, ensuring better outcomes and streamlined procedures.
Our team of clinical, scientific, and engineering experts share a commitment to advancing healthcare, guided by flexibility and a readiness to adapt to evolving market needs and technological developments.
20 October 2025
Apercure Initiates In-Hospital Clinical Trial of the LIMPIT®.
Apercure Surgical Limited is pleased to announce the commencement of its first in-hospital clinical trial for the LIMPIT® device — a next-generation securement solution for percutaneous drainage catheters and surgical drains.
The study, conducted at a leading New Zealand public hospital, marks a major step forward in validating LIMPIT’s performance in a real-world clinical setting. The trial is designed to evaluate the device’s safety, usability, and clinical efficacy across a representative cohort of surgical patients and procedures.
15 February 2025
Apercure achieves major milestone with successful completion of first clinical trial for LIMPIT® surgical device
Apercure Surgical Limited is pleased to announce the successful completion of its first clinical trial for the LIMPIT® device — a next-generation solution for securement of surgical drains. The trial evaluated the device's safety, usability, and effectiveness in a real-world clinical setting. Results confirmed that LIMPIT delivers measurable improvements in surgical precision, reduces drain-related complications, and enhances post-operative recovery when compared to traditional methods.
16th June 2024
Apercure Surgical Limited Appoints
Gregory Watts as New CEO
Apercure Surgical Limited, a leader in innovative surgical device solutions, is excited to announce the appointment of Gregory Watts as its new Chief Executive Officer. With over two decades of experience in the heath & wellbeing sectors, Gregory brings a wealth of knowledge and leadership expertise that will guide Apercure through its next phase of growth and innovation.
We’re here to help! Whether you have questions about our products, services, or clinical trials, or you’re looking to collaborate on an innovative idea, we’d love to hear from you.
Monday
9:00 am - 6:30 pm
Tuesday
9:00 am - 6:30 pm
Wednesday
9:00 am - 6:30 pm
Thursday
9:00 am - 6:30 pm
Friday
9:00 am - 6:30 pm